PSMA融合成像在前列腺癌中的应用:PET-CT与PET-MRI对比
本综述基于2016-2021年57篇原始研究,比较PSMA PET-CT与PET-MRI在前列腺癌原发灶检测、局部分期、复发及转移诊断中的性能。结论认为PET-MRI更适合局部和区域病变的分期与再分期,而PET-CT对远处骨或内脏转移的管理更有价值。
要点
- PSMA PET可补充mpMRI用于原发灶定位,尤其对PI-RADS 3分病灶有价值。
- PET-MRI在局部分期和检测局部复发方面优于PET-CT。
- PET-CT与PET-MRI在检测远处骨或内脏转移方面表现相当。
核心结论
- PET-MRI适合用于局部和区域病变的原发分期或再分期,PET-CT则对远处骨或内脏转移的管理有价值。
研究设计与样本
- 系统文献综述,检索Embase、PubMed/MEDLINE和Cochrane Library数据库,纳入2016-2021年间57篇原始研究文章。
- 纳入文献包括14篇关于PSMA放射性示踪剂、18篇关于原发肿瘤检测/局部分期/局部复发管理、17篇关于淋巴结转移管理、8篇关于骨及其他远处转移管理的研究。
关键影像表现/征象
- PSMA PET可补充mpMRI用于原发前列腺癌定位,尤其对PI-RADS 3分病灶有价值。
- PET-MRI在预测MRI隐匿性前列腺癌患者的包膜外侵犯方面具有独特优势,因此局部分期优于PET-CT。
- PET-MRI在检测局部复发方面可能优于PET-CT,在淋巴结复发检测中检出率略高于PET-CT。
- PET-CT与PET-MRI在检测远处骨或内脏转移方面表现似乎相当。
临床应用与阅片要点
- 对于原发灶定位,尤其是PI-RADS 3分病灶,可考虑PSMA PET补充mpMRI。
- 局部分期和局部复发检测优先选择PET-MRI;远处转移管理可选用PET-CT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate whether PET-CT or PET-MRI is more appropriate for imaging prostate cancer, in terms of primary tumor detection, local staging and recurrence, as well as lymph nodes and distant metastases.
METHODS: A systematic literature search was conducted on Embase, PubMed/MEDLINE, and the Cochrane Library database. Studies evaluating the diagnostic performance of PET-CT vs PET-MRI in prostate cancer patients were emphasized.
RESULTS: We reviewed 57 original research articles during the period 2016-2021: 14 articles regarding the radiotracer PSMA; 18 articles regarding the primary tumor detection, local tumor staging, managing local recurrence; 17 articles for managing lymph node metastases; and eight articles for managing bone and other distant metastases. PSMA PET could be complementary to mpMRI for primary prostate cancer localization and is particularly valuable for PI-RADS three lesions. PET-MRI is better than PET-CT in local tumor staging due to its specific benefit in predicting extracapsular extension in MRI-occult prostate cancer patients. PET-MRI is likely superior as compared with PET-CT in detecting local recurrence, and has slightly higher detection rates than PET-CT in lymph node recurrence. PET-CT and PET-MRI seem to have equivalent performance in detecting distant bony or visceral metastases.
CONCLUSION: In conclusion, PET-MRI is suitable for local and regional disease, either primary staging or restaging, whereas PET-CT is valuable for managing distant bony or visceral metastasis.
ADVANCES IN KNOWLEDGE: We reviewed the emerging applications of PET-MRI and PET-CT in clinical aspects. Readers will gain an objective overview on the strength and shortfalls of PET-MRI or PET-CT in the management of prostate cancer.
引用
- Liu, Sheng, Tseng, et al. Prostate-specific membrane antigen (PSMA) fusion imaging in prostate cancer: PET-CT vs PET-MRI. Br J Radiol. 2021. PMID: 34767482. doi:10.1259/bjr.20210728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。